Brief: NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US
16/10/2025 13:06
Oct 16 (Reuters) - NextCure Inc NXTC.O: NEXTCURE AND SIMCERE ZAIMING ANNOUNCE EXPANSION OF ONGOING PHASE 1 TRIAL OF SIM0505 (CDH6 ADC) INTO THE UNITED STATES NEXTCURE INC - TRIAL TO ACCELERATE PROOF-OF-CONCEPT DATA IN 1H 2026 Source text: ID:nGNX9m3yqn Further company coverage: NXTC.O
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview